Page 60 - DBt
P. 60
DBT-BIRAC COVID Research Consortium
DBT-BIRAC COVID-19 Research Consortium Call was announced in March
2020 to support Diagnostics, Vaccines, Novel !erapeutics, Repurposing of Drugs
or any other intervention for control of COVID-19.
Notable highlights include Phase III human clinical trials study of recombinant BCG vaccine, vaccine
development through Ind-CEPI mission, animal models for testing preclinical e%cacy, development of
in-vitro assays, upscaling of Spike protein and Receptor Binding Domain protein in large quantities to the #1YearOfModi2
vaccine and diagnostic companies as a reagent etc.
60
